EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H19N5O |
| Net Charge | 0 |
| Average Mass | 369.428 |
| Monoisotopic Mass | 369.15896 |
| SMILES | Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1 |
| InChI | InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28) |
| InChIKey | IVRXNBXKWIJUQB-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | TGFbeta receptor antagonist An antagonist that binds to and deactivates TGFβ receptors. |
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| LY-2157299 (CHEBI:137064) has role antineoplastic agent (CHEBI:35610) |
| LY-2157299 (CHEBI:137064) has role TGFβ receptor antagonist (CHEBI:91202) |
| LY-2157299 (CHEBI:137064) is a aromatic amide (CHEBI:62733) |
| LY-2157299 (CHEBI:137064) is a methylpyridines (CHEBI:25340) |
| LY-2157299 (CHEBI:137064) is a monocarboxylic acid amide (CHEBI:29347) |
| LY-2157299 (CHEBI:137064) is a pyrrolopyrazole (CHEBI:46866) |
| LY-2157299 (CHEBI:137064) is a quinolines (CHEBI:26513) |
| IUPAC Name |
|---|
| 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide |
| INNs | Source |
|---|---|
| galunisertib | WHO MedNet |
| galunisertib | WHO MedNet |
| galunisertib | WHO MedNet |
| galunisertibum | WHO MedNet |
| Synonyms | Source |
|---|---|
| LY2157299 | SUBMITTER |
| LY 2157299 | SUBMITTER |
| Manual Xrefs | Databases |
|---|---|
| Galunisertib | Wikipedia |
| D10437 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| Reaxys:14275134 | Reaxys |
| CAS:700874-72-2 | KEGG DRUG |
| Citations |
|---|